EBOOK

We are warriors
Women who use drugs reflect on parental drug use, their paths of consumption and access to services
Corina Giacomello(0)
About
Women who use drugs reflect on parental drug use, their paths of consumption and access to services.
After an initial publication on children whose parents use drugs in 2022, the Pompidou Group has continued research on this topic as part of an ongoing effort to give visibility to these children and to develop proposals for creating or strengthening services that both protect children and support families. It also intertwines with the effort of the Pompidou Group to integrate a gender dimension into drug policies in Europe.
This volume contains testimonies from 110 women who use drugs, in 11 different countries: Croatia, Cyprus, the Czech Republic, Greece, Ireland, Italy, Malta, Mexico, North Macedonia, Romania and Switzerland, and who participated in individual or collective interviews about their parental drug use, their paths of consumption and how they access services, including the barriers and facilitators encountered. Their involvement through providing valuable information on gender-responsive, drug related policies is appreciated and their contribution is recognized.
After an initial publication on children whose parents use drugs in 2022, the Pompidou Group has continued research on this topic as part of an ongoing effort to give visibility to these children and to develop proposals for creating or strengthening services that both protect children and support families. It also intertwines with the effort of the Pompidou Group to integrate a gender dimension into drug policies in Europe.
This volume contains testimonies from 110 women who use drugs, in 11 different countries: Croatia, Cyprus, the Czech Republic, Greece, Ireland, Italy, Malta, Mexico, North Macedonia, Romania and Switzerland, and who participated in individual or collective interviews about their parental drug use, their paths of consumption and how they access services, including the barriers and facilitators encountered. Their involvement through providing valuable information on gender-responsive, drug related policies is appreciated and their contribution is recognized.